Package 63323-715-05

Brand: fulvestrant

Generic: fulvestrant
NDC Package

Package Facts

Identity

Package NDC 63323-715-05
Digits Only 6332371505
Product NDC 63323-715
Product ID 63323-715_c584c51e-3ce0-4682-a4dd-d0ac149201a8
Description

2 SYRINGE, GLASS in 1 CARTON (63323-715-05) / 5 mL in 1 SYRINGE, GLASS (63323-715-01)

Marketing

Marketing Status
Marketed Since 2019-05-20
Brand fulvestrant
Generic fulvestrant
Sample Package No

Linked Drug Pages (1)

Fulvestrant ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR"], "spl_id": "c584c51e-3ce0-4682-a4dd-d0ac149201a8", "openfda": {"nui": ["N0000175582", "N0000000145", "N0000000168"], "unii": ["22X328QOC4"], "rxcui": ["727762"], "spl_set_id": ["fabe9bd8-ac23-4df1-a89a-223d5cd38914"], "pharm_class_epc": ["Estrogen Receptor Antagonist [EPC]"], "pharm_class_moa": ["Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE, GLASS in 1 CARTON (63323-715-05)  / 5 mL in 1 SYRINGE, GLASS (63323-715-01)", "package_ndc": "63323-715-05", "marketing_start_date": "20190520"}], "brand_name": "Fulvestrant", "product_id": "63323-715_c584c51e-3ce0-4682-a4dd-d0ac149201a8", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Estrogen Receptor Antagonist [EPC]", "Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "product_ndc": "63323-715", "generic_name": "Fulvestrant", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fulvestrant", "active_ingredients": [{"name": "FULVESTRANT", "strength": "50 mg/mL"}], "application_number": "NDA210326", "marketing_category": "NDA", "marketing_start_date": "20190520", "listing_expiration_date": "20261231"}